Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotrastaurin for Relapsed/Refractory CLL/SLL/PLL/RT
NCT02285244Phase 2Withdrawn
- Start
- Mar 2015
- Primary completion
- Mar 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sotrastaurin in chronic lymphocytic leukemia (CLL), chronic lymphocytic leukemia (SLL/CLL), prolymphocytic leukemia (PLL), Richter's transformation (RT), mantle cell lymphoma (MCL). Planned start Mar 2015; status: withdrawn.
02
Drugs
sotrastaurin
03
Conditions
chronic lymphocytic leukemia (CLL)chronic lymphocytic leukemia (SLL/CLL)prolymphocytic leukemia (PLL)Richter's transformation (RT)mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT02285244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02285244.